NATHBIOGEN2024-10-012024-12-31 NATHBIOGEN2024-10-012024-12-31 NATHBIOGEN2024-10-012024-12-31in-bse-fin:OneOperatingExpenses01Member NATHBIOGEN2024-10-012024-12-31in-bse-fin:OneOperatingExpenses02Member NATHBIOGEN2024-10-012024-12-31in-bse-fin:FourOperatingExpenses01Member NATHBIOGEN2024-10-012024-12-31in-bse-fin:FourOperatingExpenses02Member NATHBIOGEN2024-12-31 iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares 537291 NATHBIOGEN NOTLISTED Nath Bio-Genes (India) Limited Equity 2024-04-01 2025-03-31 2025-01-23 2025-01-15 INR Lakhs Third quarter 12:00:00 16:00:00 2025-01-23 2025-01-23 Not applicable Single segment SEED CULTIVATION 2024-10-01 2024-12-31 Unaudited Consolidated 368728000.00 4782000.00 373510000.00 868659000.00 52105000.00 -795887000.00 104881000.00 38996000.00 8250000.00 58605000.00 335609000.00 37901000.00 0.00 37901000.00 10547000.00 849000.00 11396000.00 0.00 26505000.00 0.00 0.00 0.00 0.00 26505000.00 -1169000.00 25336000.00 0.00 0.00 190040000.00 10 1.33 1.33 0.00 0.00 1.33 1.33 NOTES: (1) The Consolidated financial results were reviewed by the Audit Committee in meeting held on 22nd January 2025 and were thereafter approw Board of Directors at its meeting held on 23rd January 2025 (2) The company is dealing in one major product segment, i.e. Seed Cultivation. (3) The results have been consolidated with Nath Bio-Genes CA, Uzbekistan, where in the Company is holding 90% Equity. (4) Excess Provision made in Expenses in Sept 2024 has been reversed. (5) Investor complaints - Opening Balance - 0, Received and Resolved - 0, Closing Balance - 0 (6) The Figure have been regrouped/ rearranged where ever necessary Single segment 2024-04-01 2024-12-31 Unaudited Consolidated 3129405000.00 6839000.00 3136244000.00 1539393000.00 117818000.00 -178518000.00 261623000.00 91180000.00 24750000.00 895236000.00 2751482000.00 384762000.00 0.00 384762000.00 14373000.00 -799000.00 13574000.00 0.00 371188000.00 0.00 0.00 0.00 0.00 371188000.00 -3507000.00 367681000.00 0.00 0.00 190040000.00 10 19.35 19.35 0.00 0.00 19.35 19.35 Other Expenditure 32920000.00 Selling and Distribution Expenses 25685000.00 Other Expenditure 137845000.00 Selling and Distribution Expenses 757391000.00 1169000.00 3507000.00 0.00 0.00